| Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency B Ebrahimi Cell Regeneration 4 (1), 4: 10, 2015 | 104 | 2015 |
| A modified efficient method for dental pulp stem cell isolation M Raoof, MM Yaghoobi, A Derakhshani, AM Kamal-Abadi, B Ebrahimi, ... Dental Research Journal 11 (2), 244, 2014 | 47 | 2014 |
| In vivo reprogramming for heart regeneration: a glance at efficiency, environmental impacts, challenges and future directions B Ebrahimi Journal of Molecular and Cellular Cardiology 108, 61-72, 2017 | 23 | 2017 |
| LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer W Tang, K Ramasamy, SMA Pillai, B Santhamma, S Konda, ... Cell Death Discovery 7 (1), 216, 2021 | 18 | 2021 |
| SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance Z Liu, J Liu, B Ebrahimi, UP Pratap, Y He, KA Altwegg, W Tang, X Li, Z Lai, ... Breast Cancer Research 24 (1), 26, 2022 | 16 | 2022 |
| LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer M Li, S Viswanadhapalli, B Santhamma, UP Pratap, Y Luo, J Liu, ... Communications Biology 4 (1), 1235, 2021 | 16 | 2021 |
| Human dental pulp stem cells express many pluripotency regulators and differentiate into neuronal cells*★● B Ebrahimi, MM Yaghoobi, AM Kamal-abadi, M Raoof Neural regeneration research 6 (34), 2666-2672, 2011 | 15 | 2011 |
| Reprogramming of adult stem/progenitor cells into iPSCs without reprogramming factors B Ebrahimi Journal of Medical Hypotheses and Ideas 9 (2), 99-103, 2015 | 13 | 2015 |
| Engineering cell fate: spotlight on cell-activation and signaling-directed lineage conversion B Ebrahimi Tissue and Cell 48 (5), 475-487, 2016 | 11 | 2016 |
| Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma UP Pratap, GR Sareddy, Z Liu, PP Venkata, J Liu, W Tang, KA Altwegg, ... Neuro-Oncology Advances 3 (1), vdab099, 2021 | 10 | 2021 |
| Chemicals as the sole transformers of cell fate B Ebrahimi International journal of stem cells 9 (1), 9-20, 2016 | 10 | 2016 |
| A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer KA Altwegg, S Viswanadhapalli, M Mann, D Chakravarty, S Krishnan, ... Cancer research 82 (20), 3830-3844, 2022 | 9 | 2022 |
| Cardiac progenitor reprogramming for heart regeneration B Ebrahimi Cell Regeneration 7 (1), 1-6, 2018 | 9 | 2018 |
| Biological computational approaches: new hopes to improve (re) programming robustness, regenerative medicine and cancer therapeutics B Ebrahimi Differentiation 92 (1-2), 35-40, 2016 | 9 | 2016 |
| Chemical-only reprogramming to pluripotency B Ebrahimi Frontiers in Biology, 2016 | 9 | 2016 |
| Manufacturing a modified carbon paste electrode with catalase enzyme-Au nanoparticles for electrochemical sensing of hydrogen peroxide and their electrocatalytic properties P Sistani, A Noori, MF Motlagh, AH Tamijani, E Imani, Y Shadram, ... International Journal of Electrochemical Science 9 (7), 3680-3690, 2014 | 6 | 2014 |
| Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34 KA Altwegg, UP Pratap, Z Liu, J Liu, JR Sanchez, X Yang, B Ebrahimi, ... Breast Cancer Research and Treatment 200 (1), 151-162, 2023 | 2 | 2023 |
| Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis B Ebrahimi, S Viswanadhapalli, UP Pratap, G Rahul, X Yang, ... NPJ Precision Oncology 8 (1), 118, 2024 | | 2024 |
| Novel LIPA-Targeted Therapy for Treating Ovarian Cancer AB Collier, S Viswanadhapalli, R Gopalam, TK Lee, K Kassees, K Parra, ... Cancers 16 (3), 500, 2024 | | 2024 |
